Suo Z, Fang C, Crawford F, Mullan M
Department of Psychiatry, University of South Florida, Tampa 33613, USA.
Brain Res. 1997 Jul 11;762(1-2):144-52. doi: 10.1016/s0006-8993(97)00383-1.
The 39-42 amino acid residue amyloid beta peptide (A beta), the major protein component in senile plaques and cerebrovascular amyloidosis in the brain in Alzheimer's disease (AD), has been shown to be neurotoxic in vitro. Accumulating data from several areas suggest that cerebrovascular dysfunction and damage may also play a significant role in the AD process. For instance, we have recently demonstrated enhanced vasoconstriction and resistance to relaxation in intact rat aorta treated with A beta [Thomas et al., beta-Amyloid-mediated vasoactivity and vascular endothelial damage, Nature, 380 (1996) 168-171]. Significant vessel damage occurred after thirty minutes of exposure, but could be prevented with superoxide dismutase. To further investigate the role of A beta toxicity on endothelial cells, we have applied A beta peptides to cultures of human aortic endothelial cells (HAEC). Our results show that both A beta(1-42) and A beta(25-35) are toxic to HAEC in a time- and dose-dependent manner, and that this toxicity can be partially prevented by the calcium channel blocker, verapamil, and the antioxidant, superoxide dismutase. The common form of A beta, A beta(1-40), which has been shown to be neurotoxic, is much less toxic to HAEC. A beta toxicity to HAEC occurs within 30 min of treatment with relatively lower doses than those usually observed in primary cultured neurons and vascular smooth muscle cells. It was recently reported that a variety of mutations in the beta-amyloid protein precursor gene and the Presenilin-1 and -2 genes linked to early-onset familial AD cause an increase in the plasma concentration of A beta(1-42) in mutation carriers [Scheuner et al., Secreted amyloid beta-protein similar to that in the senile plaques of Alzheimer's disease is increased in vitro by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease, Nature Med., 2 (1996) 864-870]. Human aortic endothelial cells are more sensitive to A beta(1-42) than A beta(1-40), via a pathway involving an excess of superoxide free radicals and influx of extracellular calcium. Finally, we have evidence that both apoptotic and necrotic processes are activated by the A beta peptides in these endothelial cells.
39 - 42个氨基酸残基的β淀粉样肽(Aβ)是阿尔茨海默病(AD)患者大脑中淀粉样老年斑和脑血管淀粉样变性的主要蛋白质成分,已被证明在体外具有神经毒性。来自多个领域的越来越多的数据表明,脑血管功能障碍和损伤在AD进程中可能也起着重要作用。例如,我们最近证明,用Aβ处理的完整大鼠主动脉中血管收缩增强且对舒张的抵抗力增加[托马斯等人,β淀粉样蛋白介导的血管活性和血管内皮损伤,《自然》,380(1996)168 - 171]。暴露30分钟后发生了显著的血管损伤,但超氧化物歧化酶可预防这种损伤。为了进一步研究Aβ毒性对内皮细胞的作用,我们将Aβ肽应用于人类主动脉内皮细胞(HAEC)培养物。我们的结果表明,Aβ(1 - 42)和Aβ(25 - 35)对HAEC均具有时间和剂量依赖性毒性,并且这种毒性可被钙通道阻滞剂维拉帕米和抗氧化剂超氧化物歧化酶部分预防。常见形式的Aβ,即Aβ(1 - 40),已被证明具有神经毒性,但对HAEC的毒性要小得多。与原代培养的神经元和血管平滑肌细胞相比,用相对较低剂量的Aβ处理HAEC 30分钟内就会出现毒性。最近有报道称,与早发性家族性AD相关的β淀粉样蛋白前体基因以及早老素1和2基因中的多种突变会导致突变携带者血浆中Aβ(1 - 42)浓度升高[朔伊纳等人,与家族性阿尔茨海默病相关的早老素1和2以及APP突变在体外增加了类似于阿尔茨海默病老年斑中的分泌型淀粉样β蛋白,《自然医学》,2(1996)864 - 870]。人类主动脉内皮细胞对Aβ(1 - 42)比Aβ(1 - 40)更敏感,其途径涉及过量的超氧自由基和细胞外钙内流。最后,我们有证据表明,这些内皮细胞中的Aβ肽会激活凋亡和坏死过程。